Rapid scale Emerging high-content imaging platform with ultra-high-throughput capabilities and a recent dynamic biology extension suggests strong cross-sell opportunities to research groups seeking faster screening and more actionable data in drug discovery.

Strategic partnerships Recent collaborations with Idorsia and Okolab USA indicate a proven appetite for ecosystem partnerships; leverage co-sell and integration opportunities to target biotech and pharma customers prioritizing combined hardware and software workflows.

Data-driven growth Dual emphasis on real-time insights and AI-ready data creates upsell paths to customers aiming to deploy AI-powered discovery pipelines, offering services, analytics modules, and model training support.

Strategic leadership Appointment of a seasoned board member and a focused advisory board signals governance maturity and growth strategy; use this to engage higher-level decision-makers at mid-to-large biotech firms seeking scalable, well-governed vendors.

International expansion Switzerland market entry via Idorsia demonstrates international growth momentum; pursue regional sales plays in Europe and other regions with strong biopharma activity, emphasizing local support and regulatory-compliant deployments.